🔗 Share this article

An underground market for unapproved weight-loss medications is propelled by TikTok fitness influencers and vendors on communication apps, according to recent findings.

Investigational Treatment Gaining Traction Online

Retatrutide, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with numerous of participants share “before and after” photos, injection guides and claims of next-day UK delivery. Sellers promote the drug there before redirecting buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients lose up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to users administering substances of unknown origin.

Several professionals stated the demand for the experimental drug could be linked to the rising price of licensed weight loss treatments such as Mounjaro.

Legal Position and Implementation

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be promoted or distributed for personal consumption under the British medical regulations.

Several influencers try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and distribution can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Service Reaction and Material Removal

Based on TikTok, the platform has taken down problematic content and banned associated hashtags and search suggestions. The organization stated it was dedicated to keeping the service safe and investing in enhancing enforcement strategies.

Online Marketplace Activities

Investigations also found groups with up to 9,000 participants selling the experimental drug using Telegram's integrated discovery tool, which operates like a public directory. Typing “retatrutide” instantly displays groups with numerous of members, filled with images of slimming results, positive reviews and step-by-step instructions for mixing or administering at residence.

After moments of joining one community, a seller posted WhatsApp details, where most purchases take place. The vendor sent an instruction manual and guaranteed delivery within 48 hours. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these groups, posts show black plastic packages with Royal Mail stickers, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at home with sterile water, or pre-filled pens usually sold at £160 for 20mg. When asked how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A spokesperson for the messaging service stated it regularly monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of an online medical service connected the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You cannot know what’s contained or whether the environment they were produced in was sterile,” she explained.

Her staff has already seen individuals injured by self-injection from unverified sources. “We understand the disappointment, but purchasing from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant medical dangers”.